# Top 10 intervention extracts from dlcg_pal_onkogen_dreven_nsclc_v.1_admgodk_010724_cleaned.json

=== Ranked Intervention 1 (Extract #3, Intervention) — Score: 9 ===
retariatet
grænsning af emne
ende onkologisk behandling af EGFR-dreven NSCLC –
ret behandling vs. platinbaseret kemoterapi eller vs. første
tions TKI; er der forskel på effekt og forekomst af bivirkninger
kationsdato (periode): 2010 til dags dato
engelsk
tionstype: Primærlitteratur, herunder RCT'er
Intervention Sammenlignings Outcomes1
intervention
Osimertinib Platinum-based OR Overall respons
R OR Chemotherapy OR rate OR
Erlotinib OR Erlotinib OR Outcomes OR
R Amivantama Afatinib OR Duration of
b OR Gefitinib OR response OR
Gefitinib OR Best supportive Overall survival
Afatinib OR Care OR
Mobocertinib Pr

=== Ranked Intervention 2 (Extract #4, Intervention) — Score: 9 ===
logisk behandling af EGFR-dreven NSCLC –
ret behandling vs. platinbaseret kemoterapi eller vs. første
tions TKI; er der forskel på effekt og forekomst af bivirkninger
kationsdato (periode): 2010 til dags dato
engelsk
tionstype: Primærlitteratur, herunder RCT'er
Intervention Sammenlignings Outcomes1
intervention
Osimertinib Platinum-based OR Overall respons
R OR Chemotherapy OR rate OR
Erlotinib OR Erlotinib OR Outcomes OR
R Amivantama Afatinib OR Duration of
b OR Gefitinib OR response OR
Gefitinib OR Best supportive Overall survival
Afatinib OR Care OR
Mobocertinib Progression free
ng OR survival OR
Check

=== Ranked Intervention 3 (Extract #7, Intervention) — Score: 9 ===
latinbaseret kemoterapi eller vs. første generations TKI; er der forskel på effekt og forekomst af bivirkninger
Row 3: Inklusions- og eksklusionskriterier|Publikationsdato (periode): 2010 til dags dato Sprog: engelsk Publikationstype: Primærlitteratur, herunder RCT'er Row 1: Emneord|Populationen2|||Intervention||||Sammenlignings||Outcomes1
Row 2: ||||||||intervention||
Row 3: Engelsk Alle tænkelige søgeord bør indsættes.||Lung cancer OR|||Osimertinib||Platinum-based OR Chemotherapy OR Erlotinib OR Afatinib OR Gefitinib OR Best supportive Care|Platinum-based OR||Overall response rate OR Outcomes OR Duratio

=== Ranked Intervention 4 (Extract #1, Intervention) — Score: 3 ===
SCLC Ceritinib Overall survival
Stage IV Progression free
Oncogen-driven lung survival
cancer Adverse events
Oncogen-addicted Side effects
lung cancer Serious adverse
Lung tumor events
Metastatic
Thoracic
ALK
1 Se vejledning for Valg af tema for yderligere eksempler og beskrivelse af 'Population', 'Intervention',
'Sammenlignings intervention' og 'Outcome'.
e
Søgning efter primærlitteratur (fx randomiserede kontrollerede forsøg)
Dato for søgning Ansvarlig for søgningen
Databaser (primær litteratur)
(dd/mm/åååå) (navn(e))
PubMed 23.11.2023 Hrønn For hver database der søges i, kopieres selve søgningen ind he

=== Ranked Intervention 5 (Extract #2, Intervention) — Score: 3 ===
Stage IV Progression free
Oncogen-driven lung survival
cancer Adverse events
Oncogen-addicted Side effects
lung cancer Serious adverse
Lung tumor events
Metastatic
Thoracic
ALK
1 Se vejledning for Valg af tema for yderligere eksempler og beskrivelse af 'Population', 'Intervention',
'Sammenlignings intervention' og 'Outcome'.
e
Søgning efter primærlitteratur (fx randomiserede kontrollerede forsøg)
Dato for søgning Ansvarlig for søgningen
Databaser (primær litteratur)
(dd/mm/åååå) (navn(e))
PubMed 23.11.2023 Hrønn For hver database der søges i, kopieres selve søgningen ind herunder.
Medline (antal hits=78)

=== Ranked Intervention 6 (Extract #8, Intervention) — Score: 3 ===
er der forskel på effekt og forekomst af bivirkninger
Row 3: Inklusions- og eksklusionskriterier|Publikationsdato (periode): 2010 til dags dato Sprog: engelsk Publikationstype: Primærlitteratur, herunder RCT'er Row 1: Emneord|Populationen2|||Intervention||||Sammenlignings||Outcomes1
Row 2: ||||||||intervention||
Row 3: Engelsk Alle tænkelige søgeord bør indsættes.||Lung cancer OR|||Osimertinib||Platinum-based OR Chemotherapy OR Erlotinib OR Afatinib OR Gefitinib OR Best supportive Care|Platinum-based OR||Overall response rate OR Outcomes OR Duration of response OR Overall survival OR Progression free sur

=== Ranked Intervention 7 (Extract #9, Intervention) — Score: 3 ===
cinoma OR
Row 6: |Non-small-cell lung
Row 7: |cancer OR
Row 8: |NSCLC OR
Row 9: |Stage IV OR
Row 10: |Oncogen-driven lun
Row 11: |cancer OR
Row 12: |Oncogen-addicted
Row 13: |lung cancer OR
Row 14: |Lung tumor OR
Row 15: |Metastatic OR
Row 16: |Thoracic OR
Row 17: |EGFR
Row 18: |
Row 19: | Row 1: ||Intervention||||Sammenlignings||Outcomes1|Outcomes1
Row 2: ||||||intervention|||
Row 3: |||Osimertinib||Platinum-based OR Chemotherapy OR Erlotinib OR Afatinib OR Gefitinib OR Best supportive Care|Platinum-based OR||Overall respons rate OR Outcomes OR Duration of response OR Overall survival OR Progression free

=== Ranked Intervention 8 (Extract #10, Intervention) — Score: 3 ===
SCLC OR
Row 9: |Stage IV OR
Row 10: |Oncogen-driven lun
Row 11: |cancer OR
Row 12: |Oncogen-addicted
Row 13: |lung cancer OR
Row 14: |Lung tumor OR
Row 15: |Metastatic OR
Row 16: |Thoracic OR
Row 17: |EGFR
Row 18: |
Row 19: | Row 1: ||Intervention||||Sammenlignings||Outcomes1|Outcomes1
Row 2: ||||||intervention|||
Row 3: |||Osimertinib||Platinum-based OR Chemotherapy OR Erlotinib OR Afatinib OR Gefitinib OR Best supportive Care|Platinum-based OR||Overall respons rate OR Outcomes OR Duration of response OR Overall survival OR Progression free survival OR Adverse events OR Side effects OR Serious adverse ev

=== Ranked Intervention 9 (Extract #5, Intervention) — Score: 2 ===
portive Care Outcomes OR
Pralsetinib OR Duration of
OR response OR
Checkpoint- Overall survival
inhibitor OR OR
Pembrolizum Progression free
ab OR survival OR
Atezolizumab Adverse events
OR
Side effects OR
Serious adverse
events
ede kontrollerede forsøg)
e eksempler og beskrivelse af 'Population', 'Intervention',
e
Dato for søgning Ansvarlig for søgningen
Databaser (primær litteratur)
(dd/mm/åååå) (navn(e))
PubMed 23.11.2023 Hrønn PubMed (antal hits=59)
Items found
Search Add to builder Query
#5 Add 59
#4 Add 298.212
#3 Add 3.306
#2 Add 638
#1 Add 85.189
This message contains search results from the Natio

=== Ranked Intervention 10 (Extract #6, Intervention) — Score: 2 ===
ib OR Progression free
Checkpoint- survival OR
inhibitor OR Adverse events
Pembrolizum OR
ab OR Side effects OR
Atezolizumab Serious adverse
events
ede kontrollerede forsøg)
Dato for søgning Ansvarlig for søgningen
(dd/mm/åååå) (navn(e))
23.11.2023 Hrønn
e eksempler og beskrivelse af 'Population', 'Intervention',
e
For hver database der søges i, kopieres selve søgningen ind herunder. Items found
Search Add to builder Query
#5 Add 129
#4 Add 298.212
#3 Add 3.371
#2 Add 716
#1 Add 85.082
Sent On: Thu Nov 23 04:14:35 2023
Search: ((((Lung cancer OR Thoracic cancer OR Lung adenocarcinoma OR Non-small-cell lun

